By deubiquitinating Tau protein, the protein USP10 modulates its aggregation and thereby influences the pathogenesis of AD and other tauopathies, suggesting a possible therapeutic target for these neurodegenerative disorders [12]. This evidence concerns the gene MAPT and tauopathy.